[Treatment of heart failure: an update].
نویسندگان
چکیده
During the last years, the results of several trials on heart failure treatment were published or presented at international meetings. The new perspectives concern drug therapy and non-pharmacological strategies, such as cardioverter-defibrillators, biventricular resynchronization and implantable assist devices. Trials on beta-blockers extended the indication to patients with advanced heart failure, but the choice of the "best" beta-blocker to use remains an unsolved issue. Moreover, the concomitant use of ACE-inhibitors and angiotensin II receptor antagonists is a recent acquisition. However, the Val-HeFT results underscored that the add-on hypothesis of a more complete inhibition obtained with the combination of multiple agents was not confirmed in patients already taking ACE-inhibitors and beta-blockers. Regarding the new neurohormonal modulators (omapatrilat, etanercept, endothelin receptor blockers, arginine-vasopressin antagonists), more data are needed before using them in clinical practice. After the publication of the MADIT-II results, the cardioverter-defibrillator implantation will probably spread in patients with previous myocardial infarction and left ventricular dysfunction to prevent sudden death, but the cost-effectiveness ratio is still to be clarified. In the advanced or end-stage heart failure, when the improvement of quality of life represents the main target of therapy, ventricular resynchronization and implantable assist devices may play a role in clinical settings. Before considering them like a real therapeutic option, final results from ongoing investigations should be awaited.
منابع مشابه
The effect of self-management based discharge planning on treatment adherence in patients with heart failure
Background & Aim: Patients with heart failure experience some outcomes such as poor self-management, poor adherence to treatment and low quality of life. The aim of the current study was to evaluate the effect of self-management based discharge planning on treatment adherence in patients with heart failure. Methods & Materials: In this quasi-experimental research, 80 patients with heart failur...
متن کاملThe Impact of a Web-based Family-oriented Supportive Education Program in Adherence to Treatment of The Heart Failure Patients after Discharge from Hospital; A Randomized Clinical Trial
Background and purpose: Patient adherence to treatment is considered as an important aspect of treatment. Inadequate adherence to treatment of the heart failure (HF) patients leads to intensification of the disease, high risk of re-hospitalization and death. In this respect, this study was designed and implemented with the aim to determine the effect of a Web-based family-oriented supportive ed...
متن کاملAn Update of Pharmacological & Non-Pharmacological Therapies for COVID-19 Pandemic Trivia
The whole planet is facing one of the scariest pandemic situations in this era. On 11th February, 2020 the World Health Organization announced the name of an unknown disease as COVID-19, which is caused by the ssRNA virus SARS-CoV-2 (formally recognized as a sister of SARS-CoV and MERS-CoV). The epicenter of this disease is Wuhan, Hubei Province, China. COVID-19 can affect all age groups but pa...
متن کاملEvaluation of intravenous injection of amniotic membrane stem cells to reduce inflammatory factors in heart failure
Background: Heart failure is one of the most common cardiovascular disorders and is considered a chronic, progressive and debilitating disorder. The medical treatment of this disease is accompanied by many problems. Today, stem cells are being used increasingly to reduce the problems of heart failure treatments. Since pro-inflammatory cytokines play an important role in the prognosis and progre...
متن کاملCardiology (TSOC) for the Diagnosis and Treatment of Heart Failure
Heart failure is the major terminal pathway for most cardiovascular disease. Initial heart failure guidelines were published by American College of Cardiology (ACC) and American Heart Association (AHA) in 1995, and revised guidelines followed in 2001. Subsequently, there were another two update guidelines for diagnosis and management of heart failure published by ACC/AHA in 2005 and 2009 respec...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology
دوره 3 7 شماره
صفحات -
تاریخ انتشار 2002